FI831998A7 - Menetelmä farmaseuttisesti aktiivisten pyratsinonijohdannaisten valmistamiseksi. - Google Patents

Menetelmä farmaseuttisesti aktiivisten pyratsinonijohdannaisten valmistamiseksi. Download PDF

Info

Publication number
FI831998A7
FI831998A7 FI831998A FI831998A FI831998A7 FI 831998 A7 FI831998 A7 FI 831998A7 FI 831998 A FI831998 A FI 831998A FI 831998 A FI831998 A FI 831998A FI 831998 A7 FI831998 A7 FI 831998A7
Authority
FI
Finland
Prior art keywords
preparation
pharmaceutically active
pyrazinone derivatives
pyrazinone
derivatives
Prior art date
Application number
FI831998A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI831998L (fi
FI831998A0 (fi
Inventor
John Colin Emmett
William John Coates
Robert Antony Slater
Brian Herbert Warrington
Original Assignee
Smith Kline & French Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838300476A external-priority patent/GB8300476D0/en
Application filed by Smith Kline & French Laboratories filed Critical Smith Kline & French Laboratories
Publication of FI831998A0 publication Critical patent/FI831998A0/fi
Publication of FI831998L publication Critical patent/FI831998L/fi
Publication of FI831998A7 publication Critical patent/FI831998A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI831998A 1982-06-05 1983-06-03 Menetelmä farmaseuttisesti aktiivisten pyratsinonijohdannaisten valmistamiseksi. FI831998A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8216437 1982-06-05
GB838300476A GB8300476D0 (en) 1983-01-08 1983-01-08 Heterocyclic compounds

Publications (3)

Publication Number Publication Date
FI831998A0 FI831998A0 (fi) 1983-06-03
FI831998L FI831998L (fi) 1983-12-06
FI831998A7 true FI831998A7 (fi) 1983-12-06

Family

ID=26283037

Family Applications (1)

Application Number Title Priority Date Filing Date
FI831998A FI831998A7 (fi) 1982-06-05 1983-06-03 Menetelmä farmaseuttisesti aktiivisten pyratsinonijohdannaisten valmistamiseksi.

Country Status (15)

Country Link
US (2) US4514568A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0096517A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR840005111A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU1527583A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD209818A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK247783A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (2) ES8500244A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI831998A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR79299B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JO (1) JO1255B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO832016L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL242354A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT76791B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (1) RO86851B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZW (1) ZW12783A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657906A (en) * 1982-06-05 1987-04-14 Smith Kline & French Laboratories Ltd. Heterocyclic compounds having inotropic activity
GB8332313D0 (en) * 1983-12-02 1984-01-11 Smith Kline French Lab Chemical compounds
US4595766A (en) * 1984-10-26 1986-06-17 Ciba-Geigy Corporation Process for the preparation of an indoline carboxylic acid
US4697016A (en) * 1984-10-26 1987-09-29 Ciba-Geigy Corporation Intermediates for the preparation of a carboxylic acid
JPS62198671A (ja) * 1986-02-25 1987-09-02 Toyo Jozo Co Ltd 1−置換アルキル1,2−ジヒドロ−2−ピラジノン誘導体
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN103601792B (zh) 2007-06-04 2016-06-29 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US20130035326A1 (en) * 2009-08-19 2013-02-07 Ambit Biosciences Corporation Biaryl compounds and methods of use thereof
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
JP6215315B2 (ja) * 2012-06-12 2017-10-18 アッヴィ・インコーポレイテッド ピリジノンおよびピリダジノン誘導体
HK1218629A1 (zh) 2013-02-25 2017-03-03 Bausch Health Ireland Limited 用於结肠清洁的鸟苷酸环化酶受体激动剂
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
MX375926B (es) 2013-08-09 2025-03-07 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
EP3972599A1 (en) 2019-05-21 2022-03-30 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3745161A (en) * 1970-04-20 1973-07-10 Merck & Co Inc Phenyl-hydroxy-pyrazine carboxylic acids and derivatives

Also Published As

Publication number Publication date
US4556711A (en) 1985-12-03
RO86851B (ro) 1985-05-31
FI831998L (fi) 1983-12-06
RO86851A (ro) 1985-05-20
ES522962A0 (es) 1984-10-01
PT76791A (en) 1983-07-01
AU1527583A (en) 1983-12-08
DK247783D0 (da) 1983-06-01
PL242354A1 (en) 1984-12-17
ES8707507A1 (es) 1985-12-01
FI831998A0 (fi) 1983-06-03
ES8500244A1 (es) 1984-10-01
US4514568A (en) 1985-04-30
EP0096517A3 (en) 1985-04-03
ZW12783A1 (en) 1983-08-24
GR79299B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-10-22
DK247783A (da) 1983-12-06
EP0096517A2 (en) 1983-12-21
NO832016L (no) 1983-12-06
ES530024A0 (es) 1985-12-01
DD209818A5 (de) 1984-05-23
JO1255B1 (en) 1985-04-20
KR840005111A (ko) 1984-11-03
PT76791B (en) 1986-01-24

Similar Documents

Publication Publication Date Title
NO161372C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO832431L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
ES518692A0 (es) Metodo de preparacion de derivados farmaceuticamente activosaminoalcoil heterociclicos.
FI831998A7 (fi) Menetelmä farmaseuttisesti aktiivisten pyratsinonijohdannaisten valmistamiseksi.
NO831679L (no) Fremgangsmaate for fremstilling av farmakologisk aktive 1,3-dioksan-5-yl-alkensyrer
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
FI853649A7 (fi) Menetelmä farmaseuttisesti aktiivisten 2-(pyridyylialkeenisulfinyyli)bentsimidatsolien valmistamiseksi.
FI832004A7 (fi) Menetelmä 1-sulfo-2-oksoatsetidiini- johdannaisten valmistamiseksi.
FI823336A7 (fi) Menetelmä farmaseuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
FI892684L (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
FI882165A7 (fi) Menetelmä 4-amino-androsteenidioni-johdannaisten valmistamiseksi.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO822119L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benztriazol-derivater.
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.
FI881610A7 (fi) Menetelmä sytostaattisesti aktiivisten -rodomysinonijohdannaisten valmistamiseksi
FI842976A7 (fi) Menetelmä farmaseuttisesti aktiivisten aminopyrimidinonijohdannaisten valmistamiseksi.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: SMITH KLINE & FRENCH LABORATORIES